Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Global synthesis of the temperature sensitivity of leaf litter breakdown in streams and rivers.

Follstad Shah JJ, Kominoski JS, Ardón M, Dodds WK, Gessner MO, Griffiths NA, Hawkins CP, Johnson SL, Lecerf A, LeRoy CJ, Manning DW, Rosemond AD, Sinsabaugh RL, Swan CM, Webster JR, Zeglin LH.

Glob Chang Biol. 2016 Dec 31. doi: 10.1111/gcb.13609. [Epub ahead of print]

PMID:
28039909
2.

WATER. Saving freshwater from salts.

Cañedo-Argüelles M, Hawkins CP, Kefford BJ, Schäfer RB, Dyack BJ, Brucet S, Buchwalter D, Dunlop J, Frör O, Lazorchak J, Coring E, Fernandez HR, Goodfellow W, Achem AL, Hatfield-Dodds S, Karimov BK, Mensah P, Olson JR, Piscart C, Prat N, Ponsá S, Schulz CJ, Timpano AJ.

Science. 2016 Feb 26;351(6276):914-6. doi: 10.1126/science.aad3488. No abstract available.

PMID:
26917752
3.

Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.

Ramachandran S, Strange RC, Jones PW, Kalra S, Nayak D, Hawkins CP.

Mult Scler Relat Disord. 2014 Sep;3(5):593-9. doi: 10.1016/j.msard.2014.06.002. Epub 2014 Jun 24.

PMID:
26265271
4.

Nicotinamide promotes neuronal differentiation of mouse embryonic stem cells in vitro.

Griffin SM, Pickard MR, Orme RP, Hawkins CP, Fricker RA.

Neuroreport. 2013 Dec 18;24(18):1041-6. doi: 10.1097/WNR.0000000000000071.

PMID:
24257250
5.

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.

Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Gomez Cano M, McManus D, Mallik S, Hobart J; CUPID investigator group..

Lancet Neurol. 2013 Sep;12(9):857-65. doi: 10.1016/S1474-4422(13)70159-5. Epub 2013 Jul 13. Review.

6.

Progression of disability in multiple sclerosis: A study of factors influencing median time to reach an EDSS value.

Ramachandran S, Strange RC, Kalra S, Nayak D, Zeegers MP, Gilford J, Hawkins CP.

Mult Scler Relat Disord. 2013 Apr;2(2):109-16. doi: 10.1016/j.msard.2012.09.004. Epub 2012 Oct 24.

PMID:
25877632
7.

Epileptic seizure abolition with aromatase inhibition.

Chan KW, Kalra S, Kirby RM, Brunt AM, Hawkins CP.

J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1249-50. doi: 10.1136/jnnp-2012-302582. Epub 2012 Sep 28. No abstract available.

PMID:
23024351
8.

Multiple sclerosis and extract of cannabis: results of the MUSEC trial.

Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG; MUSEC Research Group..

J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1125-32. doi: 10.1136/jnnp-2012-302468. Epub 2012 Jul 12.

PMID:
22791906
9.

The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.

Young CA, Mills RJ, Woolmore J, Hawkins CP, Tennant A.

Mult Scler. 2012 Sep;18(9):1326-33. doi: 10.1177/1352458512436592. Epub 2012 Apr 5.

PMID:
22492132
10.

Assessing macroinvertebrate biodiversity in freshwater ecosystems: advances and challenges in DNA-based approaches.

Pfrender ME, Hawkins CP, Bagley M, Courtney GW, Creutzburg BR, Epler JH, Fend S, Schindel D, Ferrington LC Jr, Hartzell PL, Jackson S, Larsen DP, Lévesque A, Morse JC, Petersen MJ, Ruiter D, Whiting M.

Q Rev Biol. 2010 Sep;85(3):319-40. Review.

PMID:
20919633
11.

The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation.

Strange RC, Ramachandran S, Zeegers MP, Emes RD, Abraham R, Raveendran V, Boggild M, Gilford J, Hawkins CP.

Mult Scler. 2010 Sep;16(9):1109-16. doi: 10.1177/1352458510373784. Epub 2010 Jul 29.

PMID:
20670983
12.

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci.

International Multiple Sclerosis Genetics Conssortium (IMSGC)..

Genes Immun. 2010 Jul;11(5):397-405. doi: 10.1038/gene.2010.28. Epub 2010 Jun 17.

13.

Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.

Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, Fryer A, Hoban PR, Rukin N, Alldersea J, Strange RC, Hawkins CP.

Mult Scler. 2008 Nov;14(9):1280-3. doi: 10.1177/1352458508094643. Epub 2008 Jul 24.

PMID:
18653739
14.

Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis.

Woolmore J, Stone M, Holley S, Jenkinson P, Ike A, Jones P, Fryer A, Strange R, Stephens R, Langdon D, Hawkins C.

Mult Scler. 2008 Mar;14(2):177-82. Epub 2007 Oct 17.

PMID:
17942526
15.

Effects of sample standardization on mean species detectabilities and estimates of relative differences in species richness among assemblages.

Cao Y, Hawkins CP, Larsen DP, Van Sickle J.

Am Nat. 2007 Sep;170(3):381-95. Epub 2007 Jul 19.

PMID:
17879189
16.

A medical overview of encephalitis.

Stone MJ, Hawkins CP.

Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):429-49. Review.

PMID:
17676529
17.

Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.

Woolmore JA, Stone M, Pye EM, Partridge JM, Boggild M, Young C, Jones PW, Fryer AA, Hawkins CP, Strange RC.

Mult Scler. 2007 Apr;13(3):369-75.

PMID:
17439906
18.

Predictive models attribute effects on fish assemblages to toxicity and habitat alteration.

de Zwart D, Dyer SD, Posthuma L, Hawkins CP.

Ecol Appl. 2006 Aug;16(4):1295-310.

PMID:
16937798
19.
20.

Setting expectations for the ecological condition of streams: the concept of reference condition.

Stoddard JL, Larsen DP, Hawkins CP, Johnson RK, Norris RH.

Ecol Appl. 2006 Aug;16(4):1267-76.

PMID:
16937796

Supplemental Content

Loading ...
Support Center